Talk:Xenon
This is the talk page for discussing improvements to the Xenon article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1Auto-archiving period: 12 months |
Xenon is a featured article; it (or a previous version of it) has been identified as one of the best articles produced by the Wikipedia community. Even so, if you can update or improve it, please do so. | |||||||||||||||||||||||||
This article appeared on Wikipedia's Main Page as Today's featured article on February 10, 2008. | |||||||||||||||||||||||||
|
This article is written in American English, which has its own spelling conventions (color, defense, traveled) and some terms that are used in it may be different or absent from other varieties of English. According to the relevant style guide, this should not be changed without broad consensus. |
This level-4 vital article is rated FA-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
Xenon and dopping
editThe inhalation of xenon induces the Hypoxia-inducible factor 1, alpha subunit and down stream activates the production of erythropoietin. This method is used as a general method to improve the abilities of athletes.[1] [2][3][4]
References
edit- ^ "Breathe it in". the Economist. Feb 8th 2014.
{{cite news}}
: Check date values in:|date=
(help) - ^ . doi:10.1007/s00101-010-1788-5.
{{cite journal}}
: Cite journal requires|journal=
(help); Missing or empty|title=
(help) - ^ . doi:10.1681/ASN.2008070712.
{{cite journal}}
: Cite journal requires|journal=
(help); Missing or empty|title=
(help) - ^ . doi:10.1097/EJA.0b013e3283212cbb.
{{cite journal}}
: Cite journal requires|journal=
(help); Missing or empty|title=
(help)
Pronunciation is...
editzen-on? zee-non? I've always used the former but suspect it's the latter. Thoughts? 2.98.216.91 (talk) 18:15, 9 June 2017 (UTC)
- Both are fine. Double sharp (talk) 05:07, 10 June 2017 (UTC)
Xeon 124 dexay
edit124Xe decay has been observed. Bubba73 You talkin' to me? 19:42, 24 April 2019 (UTC)
Oxidation states
editI have changed the infobox OS to read:
- 0, +2, +4, +6, +8 (rarely more than 0; a weakly acidic oxide)
- from:
- 0, +1, +2, +4, +6, +8 (rarely non-0, a weakly acidic oxide)
It now aligns with {{List of OS (datacheck)}}. See also navbox {{Xenon compounds}}, and Category:Xenon compounds (13).
- It is unclear why Xe(0) would be the (only) main OS, bolded. Xe(II) "... is always used as a precursor to other organoxenon compounds". Xe(IV) is also an Organoxenon.
- The List of OS table has this source for Xe(II): "Xe(I) has been reported in xenon hexafluoroplatinate and xenon hexafluororhodate (see Pauling, Linus (1988). General Chemistry (3rd ed.). Dover Publications, Inc. p. 250. ISBN 978-0-486-65622-9.), however these compounds were later found to contain Xe(II)."
- Or are there other grounds to classify as "main"? -DePiep (talk) 10:35, 5 November 2019 (UTC)
- Because 0 is the most stable oxidation state and the one you will usually find Xe in, i.e. as the free element. The table in List of oxidation states of the elements for obvious reasons only shows 0 when it occurs in a compound (as otherwise every element would have 0). Double sharp (talk) 13:37, 5 November 2019 (UTC)
Splitting proposal
edit- The following discussion is closed. Please do not modify it. Subsequent comments should be made in a new section. A summary of the conclusions reached follows.
- The result of this discussion was to split the compounds section into Xenon compounds and leave a summary here. 141Pr {contribs} 19:20, 12 January 2024 (UTC)
I propose that the compounds section be split into Xenon compounds - the section is rather long, and it conforms with the other compounds articles. Thanks, 141Pr {contribs} 20:11, 2 January 2024 (UTC)
- Sounds good to me. Ideally, you’ll leave a paragraph-length summary and hat note here. YBG (talk) 01:16, 3 January 2024 (UTC)